
Eric Nilsson
Examiner (ID: 876, Phone: (571)272-5246 , Office: P/2122 )
| Most Active Art Unit | 2122 |
| Art Unit(s) | 2122, 2198, 2151 |
| Total Applications | 576 |
| Issued Applications | 432 |
| Pending Applications | 65 |
| Abandoned Applications | 85 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18725683
[patent_doc_number] => 20230339854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => Negative Allosteric Modulation of GluN3-Containing N-Methyl-D-Aspartate Receptors
[patent_app_type] => utility
[patent_app_number] => 17/796387
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796387
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796387 | Negative Allosteric Modulation of GluN3-Containing N-Methyl-D-Aspartate Receptors | Jan 31, 2021 | Abandoned |
Array
(
[id] => 16977530
[patent_doc_number] => 20210221767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => Crystalline Forms of Zuclomiphene Citrate
[patent_app_type] => utility
[patent_app_number] => 17/154261
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/154261 | Crystalline forms of zuclomiphene citrate | Jan 20, 2021 | Issued |
Array
(
[id] => 16946621
[patent_doc_number] => 20210205312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => TREATMENT OF MEMBRANOUS NEPHROPATHY, IGG4-RELATED DISEASE, AND ANTIPHOSPHOLIPID SYNDROME USING BTK INHIBITOR 2-[(3R)-3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-d]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE
[patent_app_type] => utility
[patent_app_number] => 17/141930
[patent_app_country] => US
[patent_app_date] => 2021-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17141930
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/141930 | TREATMENT OF MEMBRANOUS NEPHROPATHY, IGG4-RELATED DISEASE, AND ANTIPHOSPHOLIPID SYNDROME USING BTK INHIBITOR 2-[(3R)-3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-d]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE | Jan 4, 2021 | Pending |
Array
(
[id] => 18193096
[patent_doc_number] => 20230046615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => BIOMASS-BASED PESTICIDES AND METHODS OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/783316
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783316
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/783316 | BIOMASS-BASED PESTICIDES AND METHODS OF MAKING THE SAME | Dec 20, 2020 | Pending |
Array
(
[id] => 18176708
[patent_doc_number] => 20230037437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => FORMULATIONS FOR USE IN THE TREATMENT OF DIFFERENT TYPES OF ADDICTIONS AND DEPENDENCE ON ADDICTIVE SUBSTANCES
[patent_app_type] => utility
[patent_app_number] => 17/787510
[patent_app_country] => US
[patent_app_date] => 2020-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -135
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787510
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/787510 | FORMULATIONS FOR USE IN THE TREATMENT OF DIFFERENT TYPES OF ADDICTIONS AND DEPENDENCE ON ADDICTIVE SUBSTANCES | Dec 13, 2020 | Abandoned |
Array
(
[id] => 19140433
[patent_doc_number] => 20240139216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => STABLE ORAL CANNABIDIOL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/265509
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265509
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/265509 | STABLE ORAL CANNABIDIOL COMPOSITIONS | Dec 6, 2020 | Pending |
Array
(
[id] => 18139833
[patent_doc_number] => 20230013669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => Antibacterial Treatment Using a Cannabinoid and an Active Agent
[patent_app_type] => utility
[patent_app_number] => 17/778910
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778910
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778910 | Antibacterial Treatment Using a Cannabinoid and an Active Agent | Nov 26, 2020 | Abandoned |
Array
(
[id] => 18140941
[patent_doc_number] => 20230014782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => NEW SOLID STATE FORM OF LURBINECTEDIN
[patent_app_type] => utility
[patent_app_number] => 17/777985
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777985
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/777985 | NEW SOLID STATE FORM OF LURBINECTEDIN | Nov 22, 2020 | Abandoned |
Array
(
[id] => 16837794
[patent_doc_number] => 20210145806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => Methods of Treating Brain Cancer and Related Diagnostic Methods
[patent_app_type] => utility
[patent_app_number] => 16/952887
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952887
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952887 | Methods of Treating Brain Cancer and Related Diagnostic Methods | Nov 18, 2020 | Abandoned |
Array
(
[id] => 18147511
[patent_doc_number] => 20230021368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE
[patent_app_type] => utility
[patent_app_number] => 17/782807
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782807
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782807 | PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE | Nov 18, 2020 | Abandoned |
Array
(
[id] => 20622565
[patent_doc_number] => 12590062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-31
[patent_title] => PD-1/PD-L1 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/098171
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 158049
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098171
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098171 | PD-1/PD-L1 inhibitors | Nov 12, 2020 | Issued |
Array
(
[id] => 16822584
[patent_doc_number] => 20210137877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => PRODUCTS AND METHODS FOR USING CANNABIDIOL IN COMBINATION WITH MELATONIN TO INDUCE SLEEP
[patent_app_type] => utility
[patent_app_number] => 17/091091
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091091
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/091091 | PRODUCTS AND METHODS FOR USING CANNABIDIOL IN COMBINATION WITH MELATONIN TO INDUCE SLEEP | Nov 5, 2020 | Abandoned |
Array
(
[id] => 16655909
[patent_doc_number] => 20210052545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => COMPOSITIONS AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/085182
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085182
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085182 | COMPOSITIONS AND METHODS OF THEIR USE | Oct 29, 2020 | Pending |
Array
(
[id] => 16805968
[patent_doc_number] => 20210128521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => METHODS OF USING CANNABINOID COMPOSITIONS IN SPORTS MEDICINE APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/082915
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17082915
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/082915 | METHODS OF USING CANNABINOID COMPOSITIONS IN SPORTS MEDICINE APPLICATIONS | Oct 27, 2020 | Abandoned |
Array
(
[id] => 18091228
[patent_doc_number] => 20220409569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => Cannabinoid Products with High Bioavailability
[patent_app_type] => utility
[patent_app_number] => 17/772452
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772452
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/772452 | Cannabinoid Products with High Bioavailability | Oct 26, 2020 | Pending |
Array
(
[id] => 19904089
[patent_doc_number] => 12281085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/077857
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11225
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077857
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/077857 | Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof | Oct 21, 2020 | Issued |
Array
(
[id] => 18003391
[patent_doc_number] => 20220362157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => NEW HYDROCORTISONE HEMISUCCINATE LYOPHILIZATE
[patent_app_type] => utility
[patent_app_number] => 17/764584
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764584
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764584 | NEW HYDROCORTISONE HEMISUCCINATE LYOPHILIZATE | Oct 15, 2020 | Pending |
Array
(
[id] => 16760974
[patent_doc_number] => 20210106555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => PHYTOCANNABINOID FORMULATIONS AND METHODS FOR EXTRACTION
[patent_app_type] => utility
[patent_app_number] => 17/070047
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17070047
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/070047 | PHYTOCANNABINOID FORMULATIONS AND METHODS FOR EXTRACTION | Oct 13, 2020 | Abandoned |
Array
(
[id] => 18725702
[patent_doc_number] => 20230339880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => COMPOSITIONS OF AJULEMIC ACID AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/766638
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766638
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/766638 | COMPOSITIONS OF AJULEMIC ACID AND USES THEREOF | Oct 8, 2020 | Abandoned |
Array
(
[id] => 17227199
[patent_doc_number] => 20210353755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => REDUCTION OF POST-SURGERY CANCER METASTASIS BY COMBINATION OF CANNABIDIOL AND NR2F6 INHIBITION
[patent_app_type] => utility
[patent_app_number] => 17/037284
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17037284
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/037284 | Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition | Sep 28, 2020 | Issued |